Lindbrook Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $67.7K | Buy |
958
+419
| +78% | +$29.6K | 0.01% | 852 |
|
|
2024
Q4 | $35.4K | Buy |
539
+150
| +39% | +$9.86K | ﹤0.01% | 964 |
|
|
2024
Q3 | $27.3K | Buy |
389
+111
| +40% | +$7.8K | ﹤0.01% | 1121 |
|
|
2024
Q2 | $22.9K | Sell |
278
-36
| -11% | -$2.96K | ﹤0.01% | 1166 |
|
|
2024
Q1 | $27.4K | Sell |
314
-71
| -18% | -$6.2K | ﹤0.01% | 1054 |
|
|
2023
Q4 | $37.1K | Buy |
385
+278
| +260% | +$26.8K | ﹤0.01% | 877 |
|
|
2023
Q3 | $9.47K | Sell |
107
-11
| -9% | -$973 | ﹤0.01% | 1442 |
|
|
2023
Q2 | $10.2K | Buy |
118
+1
| +0.9% | +$87 | ﹤0.01% | 1453 |
|
|
2023
Q1 | $11.4K | Buy |
117
+23
| +24% | +$2.24K | ﹤0.01% | 1367 |
|
|
2022
Q4 | $9.73K | Sell |
94
-95
| -50% | -$9.83K | ﹤0.01% | 1444 |
|
|
2022
Q3 | $16K | Buy |
189
+98
| +108% | +$8.3K | ﹤0.01% | 1094 |
|
|
2022
Q2 | $8K | Buy |
91
+19
| +26% | +$1.67K | ﹤0.01% | 1338 |
|
|
2022
Q1 | $6K | Sell |
72
-10
| -12% | -$833 | ﹤0.01% | 1500 |
|
|
2021
Q4 | $7K | Buy |
82
+45
| +122% | +$3.84K | ﹤0.01% | 1391 |
|
|
2021
Q3 | $3K | Buy |
37
+3
| +9% | +$243 | ﹤0.01% | 1381 |
|
|
2021
Q2 | $3K | Buy |
34
+5
| +17% | +$441 | ﹤0.01% | 1442 |
|
|
2021
Q1 | $2K | Sell |
29
-66
| -69% | -$4.55K | ﹤0.01% | 1516 |
|
|
2020
Q4 | $8K | Buy |
95
+51
| +116% | +$4.3K | ﹤0.01% | 980 |
|
|
2020
Q3 | $3K | Buy |
44
+2
| +5% | +$136 | ﹤0.01% | 1240 |
|
|
2020
Q2 | $5K | Buy |
42
+6
| +17% | +$714 | ﹤0.01% | 1069 |
|
|
2020
Q1 | $3K | Buy |
36
+10
| +38% | +$833 | ﹤0.01% | 1158 |
|
|
2019
Q4 | $2K | Sell |
26
-69
| -73% | -$5.31K | ﹤0.01% | 1263 |
|
|
2019
Q3 | $6K | Sell |
95
-293
| -76% | -$18.5K | ﹤0.01% | 1014 |
|
|
2019
Q2 | $33K | Buy |
388
+26
| +7% | +$2.21K | 0.01% | 537 |
|
|
2019
Q1 | $32K | Hold |
362
| – | – | 0.01% | 535 |
|
|
2018
Q4 | $30K | Buy |
+362
| New | +$30K | 0.01% | 497 |
|